Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy. By continuing to use this site without changing your settings you consent to our use of cookies in accordance with our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
Sign In

Publications

Importance of patents in Chinese pharmaceutical tendering

 

14 March 2017

China has a complicated and unique tendering system for drugs – and patents play an important role in almost every tender. What adds to the complexity is that tendering rules vary between provinces. Providing necessary patent advice has become increasingly crucial to differentiating between competitors and winning tenders in China.

The main pharmaceutical market for multinational companies (MNCs) in China is the government tendering market, where government-owned hospitals procure drugs through the provincial tendering process. Each province calls for manufacturers to participate in its tendering process. These tenders are carried out for a one-to-two-year tender cycle. A company must win tenders to sell its various drugs to public hospitals within a province.

To read more, click here.

 

Publications search




Key people

David Shen
David Shen
Legal Assistant
China and Hong Kong
Telephone icon+44 20 3088 3255
Send email
View officeView profile
Jill Ge
Jill Ge
Associate
China and Hong Kong
Telephone icon+86 21 2036 7124
Send email
View officeView profile
Client alerts

Already signed up for Client alerts? Click here to access your portal



  • Add comment (optional)